md-phd student with @jbloom_lab | viral evolution and ID | @uw_mstp @uwgenome @fredhutch

Seattle, WA
So honored to have received this award! Thank you to Experiment Foundation and @navigationfund
Replying to @jbloom_lab
I’d also like to note that @CKikawa was recently given a Beyond the Journal Award for the way she has been sharing these and similar data on GitHub in real-time as they are generated: experiment.foundation/beyond
1
2
69
Caroline Kikawa retweeted
We have posted data providing real-time measurement of human neutralizing antibody landscape to seasonal influenza Data explain spread of subclades K (H3N2) & D.3.1.1 (H1N1), identify subclade K subvariants w reduced neutralization & can inform choice of strains for next vaccine
1
15
38
3,256
Caroline Kikawa retweeted
In new study led by @CKikawa, we provide near real-time data on human neutralizing antibody landscape to influenza by measuring ~26,000 titers to >100 recent viral strains. Data can inform vaccine selection & evolutionary/epidemiological modeling. biorxiv.org/content/10.1101/…
1
10
39
4,733
Caroline Kikawa retweeted
In new study led by @timcyuu, we measure how mutations to H3 flu HA affect cell entry, stability & antibody escape We find pleiotropic effects of mutations on these phenotypes shape evolution: epistasis alleviates cell-entry but not stability constraints biorxiv.org/content/10.1101/…
1
9
38
4,957
Caroline Kikawa retweeted
In study led by @CKikawa & Andrea Loes, we use new assay to measure ~10,000 neutralization titers to recent influenza strains & show titers correlate w evolutionary success of viral strains Similar data could help forecast evolution for vaccine selection biorxiv.org/content/10.1101/…
2
22
61
4,508
Caroline Kikawa retweeted
In new study led by Andrea Loes, we develop sequencing-based neutralization assay that measures replicate curves for hundreds of virus-serum pairs per 96-well plate (see image below) biorxiv.org/content/10.1101/… We apply assay to characterize response to repeat influenza vaccination
5
24
97
17,559
Overall, we found broad antibodies are harder to escape than targeted antibodies. We hope these data and further efforts to characterize Zika and dengue antigenicity aid vaccine/drug design. Here are some other highlights from our paper. If you get a chance, please check it out!
1
1
269
Thanks to awesome mentors Jesse and Leslie, collaborator @mateoinnyc, super lab mates Catiana, Jackson, @maya_contr, @LisaLevoir. Excited for the rest of grad school!
3
254